HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

TYK MEDICINES-B

11.270

+0.3603.30%

Volume:1.29M

Turnover:14.37M

Market Cap:4.28B

PE:-9.83

High:11.310

Open:10.980

Low:10.890

Close:10.910

52wk High:41.400

52wk Low:9.850

Shares:380.07M

HK Float Shares:375.46M

Volume Ratio:0.79

T/O Rate:0.34%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-1.146

ROE:--

ROA:-27.71%

PB:10.57

PE(LYR):-9.83

PS:35242.38

Loading ...

Overview Company News Filings

BRIEF-TYK Medicines' Asandeutertinib (TY-9591) To Be Included In List Of Products For Priority Review

Tyk Medicines Inc - Asandeutertinib (Ty-9591) to Be Included in List of Products for Priority Review by Nmpa China

THOMSON REUTERS

TYK Medicines Says No Undisclosed Material Events Amid Share Fluctuations

HK Movers | Innovative Drug Stocks Jump With TYK Medicines up 14%

Tiger Newspress

TYK MEDICINES-B (02410) Surges Over 10% as TY-9591 Tablets Designated for Priority Review

Zhito ng Hong Kong Stock Short Selling Statistics | January 1

TYK Medicines Appoints Jiang Xiaolin as Independent Director and Audit Committee Chair

HK Stock Movement | TYK MEDICINES-B (02410) Rises Over 5% in Early Trading as Company Prepares Conditional NDA Submission for TY-9591

HK Stock Movement | TYK MEDICINES-B (02410) Surges Over 12% Intraday as Market Focuses on Core Product TY-9591 Progress

TYK Medicines (02410) Reports No Change in Monthly Share Capital for November 2025

Bulletin Express

TYK Medicines, Inc. (02410) Announces Monthly Return on Movements in Securities for October 2025

Bulletin Express

TYK Medicines, Inc. (TYK) Announces Articles of Association (October 2025)

Bulletin Express

TYK Medicines (2410) Releases 2025 Second EGM Poll Results

Bulletin Express

TYK Medicines Inc. Held Extraordinary General Meeting

HK Stock Movement | TYK MEDICINES-B (02410) Rises Nearly 7% Before Noon as Company Presents Positive Clinical Data on Multiple CDK Inhibitors at ESMO Annual Meeting

Financial Insights on Hong Kong Stocks | Severe Price Correction in Gold and Silver, Institutions Affirm Strong Fundamental Support for Precious Metal Rally

TYK Medicines, Inc. (2410) Announces Positive CDK Inhibitor Data at ESMO 2025

Bulletin Express

TYK Medicines Announces Positive Early Clinical Data for CDK Inhibitors at ESMO 2025

TYK MEDICINES-B (02410): Positive Clinical Data on Multiple CDK Inhibitors Presented at ESMO 2025

TYK MEDICINES-B (02410) Proposes Adoption of 2025 H-Share Incentive Plan

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/02410/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02410","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02410\",,,,,undefined,":{"symbol":"02410","market":"HK","secType":"STK","nameCN":"TYK MEDICINES-B","latestPrice":11.27,"timestamp":1773821285004,"preClose":10.91,"halted":0,"volume":1291000,"delay":0,"changeRate":0.03299725022914752,"floatShares":375457818,"shares":380065818,"eps":-1.146139,"marketStatus":"Not Yet Opened","change":0.36,"latestTime":"03-18 16:08:05","open":10.98,"high":11.31,"low":10.89,"amount":14367150,"amplitude":0.038497,"askPrice":11.27,"askSize":212000,"bidPrice":11.23,"bidSize":1000,"shortable":3,"etf":0,"ttmEps":-0.845803,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1773883800000},"marketStatusCode":0,"adr":0,"listingDate":1724083200000,"exchange":"SEHK","adjPreClose":10.91,"openAndCloseTimeList":[[1773797400000,1773806400000],[1773810000000,1773820800000]],"volumeRatio":0.7885414122008294,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02410\",,,,,undefined,":{"symbol":"02410","floatShares":375457818,"roa":"-27.71%","roe":"--","lyrEps":-1.146139,"volumeRatio":0.7885414122008294,"shares":380065818,"dividePrice":0,"high":11.31,"amplitude":0.038497,"preClose":10.91,"low":10.89,"week52Low":9.85,"pbRate":"10.57","psRate":"35242.38","week52High":41.4,"institutionHeld":0,"latestPrice":11.27,"committee":-0.99061,"eps":-1.146139,"divideRate":0,"volume":1291000,"delay":0,"ttmEps":-0.845803,"open":10.98,"prevYearClose":13.11,"prevWeekClose":10.8,"prevMonthClose":12.6,"prevQuarterClose":13.11,"fiveDayClose":11.03,"twentyDayClose":12.8,"sixtyDayClose":13.39},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02410\",params:#limit:5,,,undefined,":[{"date":"2025-08-31","symbol":"02410","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756603800000,"name":null,"time":"","dateTimestamp":1756569600000,"actualEps":null},{"date":"2025-03-27","symbol":"02410","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1743039000000,"name":null,"time":"","dateTimestamp":1743004800000,"actualEps":null},{"date":"2024-08-30","symbol":"02410","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724981400000,"name":null,"time":"","dateTimestamp":1724947200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02410\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02410\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1747411200000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02410\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02410","date":"2026-03-17","current":-13.324616,"percent":0.966408,"low":-45.171338,"twenty":-24.759735,"median":-18.497771,"eighty":-15.810088,"high":-10.104382,"avg":-20.469347,"sd":6.172709,"marketCap":4146518074},"quantilePoints":[{"date":"2024-08-23","current":-18.036629,"twenty":-16.647141,"median":-14.72623,"eighty":-12.008468,"marketCap":8010053668},{"date":"2024-08-30","current":-17.916348,"twenty":-18.108709,"median":-17.490261,"eighty":-14.277882,"marketCap":8010053668},{"date":"2024-09-06","current":-22.38992,"twenty":-20.387629,"median":-17.957821,"eighty":-15.985061,"marketCap":10531737231},{"date":"2024-09-13","current":-25.215246,"twenty":-24.52304,"median":-18.767123,"eighty":-16.911292,"marketCap":11829662594},{"date":"2024-09-20","current":-22.432724,"twenty":-24.518581,"median":-20.496807,"eighty":-17.208183,"marketCap":10587362603},{"date":"2024-09-27","current":-24.719835,"twenty":-24.497927,"median":-22.38992,"eighty":-17.671485,"marketCap":11736953639},{"date":"2024-10-04","current":-24.95032,"twenty":-24.87878,"median":-23.321155,"eighty":-17.932937,"marketCap":11792579012},{"date":"2024-10-10","current":-25.38933,"twenty":-24.941363,"median":-23.362473,"eighty":-17.973583,"marketCap":11922371548},{"date":"2024-10-18","current":-26.355956,"twenty":-25.311733,"median":-23.798709,"eighty":-18.108709,"marketCap":12311749157},{"date":"2024-10-25","current":-24.571342,"twenty":-25.374683,"median":-24.122054,"eighty":-18.545067,"marketCap":11477368567},{"date":"2024-11-01","current":-18.445843,"twenty":-25.311733,"median":-23.998666,"eighty":-18.584118,"marketCap":8621932768},{"date":"2024-11-08","current":-20.323115,"twenty":-25.278482,"median":-23.623818,"eighty":-17.973583,"marketCap":9456313359},{"date":"2024-11-15","current":-19.45318,"twenty":-25.171449,"median":-23.425489,"eighty":-18.108709,"marketCap":8955685004},{"date":"2024-11-22","current":-24.620137,"twenty":-24.988066,"median":-23.362473,"eighty":-18.406793,"marketCap":11329034239},{"date":"2024-11-29","current":-31.047836,"twenty":-25.311733,"median":-23.554037,"eighty":-18.584118,"marketCap":14277178993},{"date":"2024-12-06","current":-34.758675,"twenty":-25.786797,"median":-23.737743,"eighty":-19.168188,"marketCap":15945940174},{"date":"2024-12-13","current":-35.961329,"twenty":-26.0415,"median":-24.070769,"eighty":-19.324298,"marketCap":16465110319},{"date":"2024-12-20","current":-44.500897,"twenty":-30.298107,"median":-24.44033,"eighty":-19.494791,"marketCap":20284719244},{"date":"2024-12-27","current":-43.273475,"twenty":-31.455257,"median":-24.553474,"eighty":-19.619623,"marketCap":19709923726},{"date":"2025-01-03","current":-39.042242,"twenty":-33.760908,"median":-24.669986,"eighty":-19.709581,"marketCap":17800119264},{"date":"2025-01-10","current":-16.73771,"twenty":-34.083555,"median":-24.719835,"eighty":-19.709581,"marketCap":7602134269},{"date":"2025-01-17","current":-16.071561,"twenty":-33.760908,"median":-24.553474,"eighty":-18.860667,"marketCap":7305465614},{"date":"2025-01-24","current":-20.268382,"twenty":-32.413923,"median":-24.349989,"eighty":-19.230133,"marketCap":9270895450},{"date":"2025-01-28","current":-18.549699,"twenty":-31.591026,"median":-24.122054,"eighty":-18.549699,"marketCap":8529223814},{"date":"2025-02-07","current":-17.965815,"twenty":-31.472067,"median":-23.871541,"eighty":-18.275892,"marketCap":8214013368},{"date":"2025-02-14","current":-19.878813,"twenty":-31.451054,"median":-23.623818,"eighty":-18.275892,"marketCap":9066935750},{"date":"2025-02-21","current":-25.066745,"twenty":-31.047836,"median":-23.789321,"eighty":-18.32609,"marketCap":11495910358},{"date":"2025-02-28","current":-26.244856,"twenty":-30.411824,"median":-23.765234,"eighty":-18.39703,"marketCap":11996538712},{"date":"2025-03-07","current":-24.725844,"twenty":-30.135297,"median":-23.927628,"eighty":-18.445843,"marketCap":11347576030},{"date":"2025-03-14","current":-23.101371,"twenty":-29.84324,"median":-23.977848,"eighty":-18.549699,"marketCap":10605904394},{"date":"2025-03-21","current":-22.868028,"twenty":-28.789228,"median":-23.789321,"eighty":-18.691799,"marketCap":10494653649},{"date":"2025-03-28","current":-28.703724,"twenty":-28.703724,"median":-23.977848,"eighty":-19.110968,"marketCap":13146129748},{"date":"2025-04-03","current":-29.204856,"twenty":-29.744706,"median":-24.122054,"eighty":-19.131966,"marketCap":12070705875},{"date":"2025-04-11","current":-24.387234,"twenty":-29.307899,"median":-24.067881,"eighty":-19.145106,"marketCap":10012567086},{"date":"2025-04-17","current":-24.599189,"twenty":-28.955479,"median":-24.067881,"eighty":-19.224594,"marketCap":10123817831},{"date":"2025-04-25","current":-24.758022,"twenty":-28.755026,"median":-24.236021,"eighty":-19.282593,"marketCap":10197984995},{"date":"2025-05-02","current":-30.859428,"twenty":-28.772127,"median":-24.368612,"eighty":-19.308976,"marketCap":12738210348},{"date":"2025-05-09","current":-26.222368,"twenty":-28.789228,"median":-24.487968,"eighty":-19.376573,"marketCap":11477368567},{"date":"2025-05-16","current":-19.875071,"twenty":-28.703724,"median":-24.44033,"eighty":-19.45318,"marketCap":8770267095},{"date":"2025-05-23","current":-18.391406,"twenty":-28.460584,"median":-24.320388,"eighty":-19.147078,"marketCap":8139846205},{"date":"2025-05-30","current":-16.767615,"twenty":-28.328721,"median":-24.116277,"eighty":-18.777931,"marketCap":7453799941},{"date":"2025-06-06","current":-19.720458,"twenty":-27.077703,"median":-23.93026,"eighty":-18.847277,"marketCap":8788808886},{"date":"2025-06-13","current":-16.18601,"twenty":-26.697665,"median":-23.850097,"eighty":-18.709822,"marketCap":7216465018},{"date":"2025-06-20","current":-14.05098,"twenty":-26.664525,"median":-23.778892,"eighty":-18.426653,"marketCap":6252291891},{"date":"2025-06-27","current":-16.3221,"twenty":-26.630078,"median":-23.66211,"eighty":-18.32609,"marketCap":7283215465},{"date":"2025-07-04","current":-17.493079,"twenty":-26.41078,"median":-23.623818,"eighty":-18.194509,"marketCap":7806093968},{"date":"2025-07-11","current":-16.487526,"twenty":-26.267076,"median":-23.430941,"eighty":-17.964216,"marketCap":7349965912},{"date":"2025-07-18","current":-15.867745,"twenty":-26.226866,"median":-23.321155,"eighty":-17.866761,"marketCap":7068130691},{"date":"2025-07-25","current":-16.407488,"twenty":-26.143659,"median":-23.070409,"eighty":-17.335488,"marketCap":7335132480},{"date":"2025-08-01","current":-14.539711,"twenty":-26.072617,"median":-22.868028,"eighty":-17.325642,"marketCap":6459959949},{"date":"2025-08-08","current":-15.316665,"twenty":-25.987382,"median":-22.563641,"eighty":-17.04089,"marketCap":6822181433},{"date":"2025-08-15","current":-17.450454,"twenty":-25.968574,"median":-22.406203,"eighty":-16.915178,"marketCap":7760944003},{"date":"2025-08-22","current":-13.484776,"twenty":-25.95357,"median":-22.354126,"eighty":-16.718364,"marketCap":5978435317},{"date":"2025-08-29","current":-12.516323,"twenty":-25.925655,"median":-21.46252,"eighty":-16.486483,"marketCap":5575565550},{"date":"2025-09-05","current":-19.23268,"twenty":-25.919389,"median":-21.226743,"eighty":-16.486483,"marketCap":5883418862},{"date":"2025-09-12","current":-18.156363,"twenty":-25.850806,"median":-20.678772,"eighty":-16.541494,"marketCap":5564163575},{"date":"2025-09-19","current":-18.839434,"twenty":-25.807696,"median":-20.500943,"eighty":-16.56352,"marketCap":5769399117},{"date":"2025-09-26","current":-19.348832,"twenty":-25.743581,"median":-20.268382,"eighty":-16.654406,"marketCap":5910023469},{"date":"2025-10-03","current":-22.468168,"twenty":-25.650075,"median":-20.314843,"eighty":-16.707921,"marketCap":6879191305},{"date":"2025-10-10","current":-19.927643,"twenty":-25.596841,"median":-20.323115,"eighty":-16.732368,"marketCap":6092455062},{"date":"2025-10-17","current":-19.134493,"twenty":-25.519561,"median":-20.155539,"eighty":-16.749672,"marketCap":5845412280},{"date":"2025-10-24","current":-17.635142,"twenty":-25.404318,"median":-19.980008,"eighty":-16.781291,"marketCap":5389333299},{"date":"2025-10-31","current":-19.024541,"twenty":-25.400784,"median":-19.927643,"eighty":-16.830147,"marketCap":5822608331},{"date":"2025-11-07","current":-17.694439,"twenty":-25.37593,"median":-19.869193,"eighty":-16.945559,"marketCap":5412137248},{"date":"2025-11-14","current":-17.099248,"twenty":-25.321084,"median":-19.741813,"eighty":-16.951188,"marketCap":5244908288},{"date":"2025-11-21","current":-15.19815,"twenty":-25.311733,"median":-19.694587,"eighty":-16.919035,"marketCap":4659606928},{"date":"2025-11-28","current":-16.711808,"twenty":-25.293455,"median":-19.641679,"eighty":-16.730587,"marketCap":5142290517},{"date":"2025-12-05","current":-17.262657,"twenty":-25.275139,"median":-19.635782,"eighty":-16.587841,"marketCap":5320921452},{"date":"2025-12-12","current":-16.160016,"twenty":-25.213434,"median":-19.544821,"eighty":-16.497144,"marketCap":4990264190},{"date":"2025-12-19","current":-16.355316,"twenty":-25.19336,"median":-19.414876,"eighty":-16.454475,"marketCap":5062476695},{"date":"2025-12-24","current":-15.692499,"twenty":-25.154877,"median":-19.348832,"eighty":-16.406101,"marketCap":4872443786},{"date":"2026-01-02","current":-15.765099,"twenty":-25.10227,"median":-19.292077,"eighty":-16.35327,"marketCap":4914251026},{"date":"2026-01-09","current":-17.392186,"twenty":-25.070347,"median":-19.235279,"eighty":-16.345574,"marketCap":5434941197},{"date":"2026-01-16","current":-16.438751,"twenty":-25.06473,"median":-19.137216,"eighty":-16.35327,"marketCap":5153692492},{"date":"2026-01-23","current":-15.75073,"twenty":-25.023112,"median":-19.120814,"eighty":-16.314941,"marketCap":4933254317},{"date":"2026-01-30","current":-15.280433,"twenty":-24.971672,"median":-19.022068,"eighty":-16.22453,"marketCap":4807832597},{"date":"2026-02-06","current":-15.542994,"twenty":-24.952303,"median":-18.937078,"eighty":-16.152588,"marketCap":4902849052},{"date":"2026-02-13","current":-15.334427,"twenty":-24.923448,"median":-18.860882,"eighty":-16.099082,"marketCap":4864842470},{"date":"2026-02-20","current":-15.572498,"twenty":-24.905533,"median":-18.847277,"eighty":-16.071561,"marketCap":4933254317},{"date":"2026-02-27","current":-14.952615,"twenty":-24.827654,"median":-18.801141,"eighty":-15.988536,"marketCap":4788829306},{"date":"2026-03-06","current":-13.279596,"twenty":-24.77147,"median":-18.709822,"eighty":-15.892604,"marketCap":4218730579},{"date":"2026-03-13","current":-12.861452,"twenty":-24.760877,"median":-18.616931,"eighty":-15.828013,"marketCap":4104710834},{"date":"2026-03-17","current":-13.010504,"twenty":-24.759735,"median":-18.497771,"eighty":-15.810088,"marketCap":4146518074}],"updateTime":1773851661946},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02410\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2601801750","title":"BRIEF-TYK Medicines' Asandeutertinib (TY-9591) To Be Included In List Of Products For Priority Review","url":"https://stock-news.laohu8.com/highlight/detail?id=2601801750","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601801750?lang=en_us&edition=fundamental","pubTime":"2026-01-07 22:45","pubTimestamp":1767797112,"startTime":"0","endTime":"0","summary":"BRIEF-TYK Medicines' Asandeutertinib (TY-9591) To Be Included In List Of Products For Priority ReviewJan 7 (Reuters) - TYK Medicines Inc 2410.HK:ASANDEUTERTINIB (TY-9591) TO BE INCLUDED IN LIST OF PRO","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260107:nFWN3Y802O:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02410"],"gpt_icon":0},{"id":"2601880144","title":"Tyk Medicines Inc - Asandeutertinib (Ty-9591) to Be Included in List of Products for Priority Review by Nmpa China","url":"https://stock-news.laohu8.com/highlight/detail?id=2601880144","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601880144?lang=en_us&edition=fundamental","pubTime":"2026-01-07 22:43","pubTimestamp":1767797027,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260107:nFWN3Y802O:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02410","BK1161"],"gpt_icon":0},{"id":"2601801415","title":"TYK Medicines Says No Undisclosed Material Events Amid Share Fluctuations","url":"https://stock-news.laohu8.com/highlight/detail?id=2601801415","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601801415?lang=en_us&edition=fundamental","pubTime":"2026-01-07 22:43","pubTimestamp":1767796985,"startTime":"0","endTime":"0","summary":"TYK Medicines Inc. issued a statement confirming that its business operations remain normal and stable, with core business progressing smoothly. The company clarified that, aside from the proposed inclusion of its investigational drug Asandeutertinib  in the priority review list for first-line treatment of certain non-small cell lung cancer patients, there are no other material matters requiring disclosure. The board also noted recent unusual fluctuations in the company’s share price and trading volume, and stated it is not aware of any undisclosed information or reasons for such movements. Investors are advised to exercise caution, as there is no assurance that the relevant product will ultimately be successfully developed and marketed.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be inter","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260107:nNDLNhVJH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02410","BK1161"],"gpt_icon":0},{"id":"1155519341","title":"HK Movers | Innovative Drug Stocks Jump With TYK Medicines up 14%","url":"https://stock-news.laohu8.com/highlight/detail?id=1155519341","media":"Tiger Newspress","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155519341?lang=en_us&edition=fundamental","pubTime":"2026-01-07 09:57","pubTimestamp":1767751062,"startTime":"0","endTime":"0","summary":"Innovative drug stocks jumped in Hong Kong. TYK Medicines rose 14%; Lepu Biopharma rose 5%; Akeso and Hengrui Pharm rose 4%; HUTCHMED rose 3%.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"8cf272575aa59c1c9fc76dc7d5dd9c50","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09926","02410","02157","01276","00013"],"gpt_icon":0},{"id":"1135622162","title":"TYK MEDICINES-B (02410) Surges Over 10% as TY-9591 Tablets Designated for Priority Review","url":"https://stock-news.laohu8.com/highlight/detail?id=1135622162","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1135622162?lang=en_us&edition=fundamental","pubTime":"2026-01-07 09:48","pubTimestamp":1767750500,"startTime":"0","endTime":"0","summary":"TYK MEDICINES-B (02410) rose more than 10%, and as of the time of writing, it was up 7.97% to HKD 13.95, with a turnover of HKD 32.6634 million. On January 6, the CDE website indicated that the...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1161","09939","02410","BK1515","159938","TY"],"gpt_icon":0},{"id":"1183450710","title":"Zhito ng Hong Kong Stock Short Selling Statistics | January 1","url":"https://stock-news.laohu8.com/highlight/detail?id=1183450710","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1183450710?lang=en_us&edition=fundamental","pubTime":"2026-01-01 08:25","pubTimestamp":1767227103,"startTime":"0","endTime":"0","summary":"In the previous trading session, CKH Holdings (00001), CLP Holdings (00002), and HK & China Gas (00003) recorded the highest short selling ratios, each at 0.00%. These three stocks also led in terms...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00012","02562","LU0898667661.SGD","LU1497734951.SGD","00006","BK1230","BK1536","BK1216","LU1497733557.USD","01709","BK1534","02589","LU1497733631.SGD","SG9999002950.SGD","BK1559","BK1189","BK1221","00001","03143","BK1233","LU0516422952.EUR","LU0516422366.SGD","LU0417516738.SGD","00003","BK1231","BK1240","LU1522347837.USD","LU1481107354.HKD","HSHD.SI","BK1229","BK1527","00010","LU2663582299.SGD","BK1610","01635","HSBC","LU0516423174.USD","LU0634319403.HKD","BK1161","SG9999001093.SGD","BK1521","LU0831103253.SGD","BK1124","HSNGY","LU0072462343.USD","IE0032431581.USD","BK1616","LU0149721374.USD","00011","BK1577","BK1099","BK1237","BK1500","BK1601","01142","BK1138","LU1634259391.SGD","BK1171","06681","HSBA.UK","LU1634259557.SGD","BK1258","BK1111","02410","80011","BK1109","03145","IE00BG0RBZ43.SGD","LU0348735423.USD","LU0516422440.USD","00004","IE00BHRH8C09.USD","LU1048588211.SGD","00317","SG9999003461.SGD","LU0164880469.USD","00005","BK1587","LU1508157978.USD","BK1133","LU0540923850.HKD","LU1571399168.USD","06683","02451","LU1981816686.USD","00002","BK1569","LU0516423091.SGD","BK1572","00008"],"gpt_icon":0},{"id":"2590579089","title":"TYK Medicines Appoints Jiang Xiaolin as Independent Director and Audit Committee Chair","url":"https://stock-news.laohu8.com/highlight/detail?id=2590579089","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590579089?lang=en_us&edition=fundamental","pubTime":"2025-12-12 16:31","pubTimestamp":1765528262,"startTime":"0","endTime":"0","summary":"TYK Medicines Inc. has announced the appointment of Mr. Jiang Xiaolin as an independent non-executive director. Mr. Jiang will also serve as chairman of the audit committee and as a member of the remuneration and appraisal committee and the nomination committee.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. TYK Medicines Inc. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on December 12, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251212:nNDL7R3BtS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02410"],"gpt_icon":0},{"id":"1158828960","title":"HK Stock Movement | TYK MEDICINES-B (02410) Rises Over 5% in Early Trading as Company Prepares Conditional NDA Submission for TY-9591","url":"https://stock-news.laohu8.com/highlight/detail?id=1158828960","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158828960?lang=en_us&edition=fundamental","pubTime":"2025-12-12 11:06","pubTimestamp":1765508778,"startTime":"0","endTime":"0","summary":"TYK MEDICINES-B (02410) surged more than 5% in early trading, and as of press time, it was up 3.73% at HK$13.35, with a turnover of HK$21.546 million. The company's EGFR-targeted high-selective...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02410","159938","BK1574","09939","BK1161","BK1515","TY"],"gpt_icon":0},{"id":"1163504277","title":"HK Stock Movement | TYK MEDICINES-B (02410) Surges Over 12% Intraday as Market Focuses on Core Product TY-9591 Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=1163504277","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1163504277?lang=en_us&edition=fundamental","pubTime":"2025-12-05 15:08","pubTimestamp":1764918495,"startTime":"0","endTime":"0","summary":"TYK MEDICINES-B (02410) rose more than 12% intraday, with gains narrowing to 7.16% by press time at HK$14.21, recording a turnover of HK$132 million. The surge follows heightened market attention on...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","BK1161","TY","BK1574","159938","09939","02410"],"gpt_icon":0},{"id":"1104066270","title":"TYK Medicines (02410) Reports No Change in Monthly Share Capital for November 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=1104066270","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1104066270?lang=en_us&edition=fundamental","pubTime":"2025-12-03 16:47","pubTimestamp":1764751622,"startTime":"0","endTime":"0","summary":"TYK Medicines, Inc. (Stock Code: 02410) has released its monthly return on securities movements for the period ended 30 November 2025. According to the announcement, the company’s registered share...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02410"],"gpt_icon":0},{"id":"1117396766","title":"TYK Medicines, Inc. (02410) Announces Monthly Return on Movements in Securities for October 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=1117396766","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1117396766?lang=en_us&edition=fundamental","pubTime":"2025-11-04 16:46","pubTimestamp":1762246003,"startTime":"0","endTime":"0","summary":"TYK Medicines, Inc. (the “Company”) (02410) reported no changes to its registered H share capital and unlisted share capital for the month ended 31 October 2025. The registered H share capital...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02410"],"gpt_icon":0},{"id":"1170971249","title":"TYK Medicines, Inc. (TYK) Announces Articles of Association (October 2025)","url":"https://stock-news.laohu8.com/highlight/detail?id=1170971249","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1170971249?lang=en_us&edition=fundamental","pubTime":"2025-10-30 21:49","pubTimestamp":1761832156,"startTime":"0","endTime":"0","summary":"TYK Medicines, Inc. (Chinese name: 浙江同源康醫藥股份有限公司) released its updated Articles of Association dated October 2025. According to the document, TYK Medicines, Inc. is a joint stock limited company...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02410"],"gpt_icon":0},{"id":"1155308138","title":"TYK Medicines (2410) Releases 2025 Second EGM Poll Results","url":"https://stock-news.laohu8.com/highlight/detail?id=1155308138","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155308138?lang=en_us&edition=fundamental","pubTime":"2025-10-30 21:26","pubTimestamp":1761830806,"startTime":"0","endTime":"0","summary":"TYK Medicines, Inc (Stock Code: 2410) held its 2025 second extraordinary general meeting (EGM) on October 30, 2025, in Shanghai. The meeting was chaired by the Chairman of the Board, and attended by...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02410"],"gpt_icon":0},{"id":"2579226119","title":"TYK Medicines Inc. Held Extraordinary General Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2579226119","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579226119?lang=en_us&edition=fundamental","pubTime":"2025-10-30 18:18","pubTimestamp":1761819527,"startTime":"0","endTime":"0","summary":"TYK Medicines Inc. held its 2025 second extraordinary general meeting on October 30, 2025. The meeting included proposals put forward to shareholders. All proposals were approved.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. TYK Medicines Inc. published the original content used to generate this news brief on October 30, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251030:nNDLc1BBc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02410"],"gpt_icon":0},{"id":"1195241532","title":"HK Stock Movement | TYK MEDICINES-B (02410) Rises Nearly 7% Before Noon as Company Presents Positive Clinical Data on Multiple CDK Inhibitors at ESMO Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=1195241532","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195241532?lang=en_us&edition=fundamental","pubTime":"2025-10-28 11:56","pubTimestamp":1761623776,"startTime":"0","endTime":"0","summary":"TYK MEDICINES-B (02410) surged nearly 7% before noon, gaining 5.82% to HKD 15.08 by the time of writing, with a turnover of HKD 73.088 million. The company recently announced that early clinical...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02410","BK1515","BK1574","159938","09939"],"gpt_icon":0},{"id":"1117330990","title":"Financial Insights on Hong Kong Stocks | Severe Price Correction in Gold and Silver, Institutions Affirm Strong Fundamental Support for Precious Metal Rally","url":"https://stock-news.laohu8.com/highlight/detail?id=1117330990","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1117330990?lang=en_us&edition=fundamental","pubTime":"2025-10-22 07:50","pubTimestamp":1761090630,"startTime":"0","endTime":"0","summary":"Today’s headlines indicate a steep correction in gold and silver prices, with international gold and silver witnessing significant declines. Spot gold dropped 5.18% to $4,130.41 per ounce, marking...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"70c4ec2eb3fbd1c377984904e60ac1b1","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4023","LU1807302812.USD","BK1221","LU2360107168.USD","BK4613","BK1502","LU0353189680.USD","BK1224","LU2290526834.HKD","LU0164880469.USD","BK1506","LU0287142896.SGD","01208","BK1133","BK1538","BK0188","LU1861215975.USD","LU1960683339.HKD","LU0211977185.USD","GCmain","BK1589","LU0823426308.USD","LU0173614495.USD","BK0012","LU0327786744.USD","LU0499858438.USD","LU0359202008.SGD","DUST","BK1602","02410","01088","IAU","LU1861220033.SGD","GLD","BK0215","BK4539","LU0348766576.USD","LU0572944931.SGD","LU0588546209.SGD","IE00B19Z9Z06.USD","LU0611395673.USD","LU0499858602.USD","BK1545","00728","09992","MGCmain","BK1592","BK1536","IE00B19Z9P08.USD","LU0348767384.USD","LU1770036033.HKD","518880","LU0097036916.USD","LU0149721374.USD","IE00BZ9MQY76.HKD","00590","BK0028","BK1610","BK1161","BK1155","00392","BK1116","000729","LU1852331112.SGD","LU1993786604.SGD","LU0823426480.USD","BK1566","SGXZ62798434.SGD","NUGT","LU0531971595.HKD","BK1190","LU0039217434.USD","BK1505","02498","03750","SGUmain","QOmain","LU2087625088.SGD","LU0164865239.USD","SGCmain","159934","IE00B894F039.SGD","APP","LU0359201885.HKD","LU1023057109.AUD","LU2063271972.USD","BK4585","LU0056508442.USD","SG9999001069.SGD","BK1601","BK4588","1OZmain","SG9999002950.SGD","LU0359201612.USD","SGXZ86797644.SGD","LU0231483743.USD","BK1594","LU2543165471.USD","IE0034224299.USD","GDX","LU2250418816.HKD","LU0593848301.USD","LU0307460666.USD","02477","LU0345776255.USD","BK1179","LU2360106780.USD","BK1178","LU0345775950.USD","BK4608","LU0871576103.HKD","LU1481107354.HKD"],"gpt_icon":1},{"id":"1194507614","title":"TYK Medicines, Inc. (2410) Announces Positive CDK Inhibitor Data at ESMO 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=1194507614","media":"Bulletin Express","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194507614?lang=en_us&edition=fundamental","pubTime":"2025-10-21 20:22","pubTimestamp":1761049352,"startTime":"0","endTime":"0","summary":"TYK Medicines, Inc. (Stock Code: 2410) presented early-phase clinical study findings for three cyclin-dependent kinase (CDK) inhibitor candidates—TYK-00540 (CDK2/4i), TY-2699a (CDK7i), and TY-302...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02410"],"gpt_icon":0},{"id":"2577820680","title":"TYK Medicines Announces Positive Early Clinical Data for CDK Inhibitors at ESMO 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2577820680","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577820680?lang=en_us&edition=fundamental","pubTime":"2025-10-21 20:15","pubTimestamp":1761048917,"startTime":"0","endTime":"0","summary":"TYK Medicines Inc. has announced positive early-phase clinical study results for three of its key cyclin-dependent kinase  inhibitor candidates: TYK-00540 , TY-2699a , and TY-302 . The data were presented as posters at the European Society for Medical Oncology  Congress 2025, held in Berlin, Germany from October 17 to 21, 2025. Among the findings, TYK-00540 demonstrated encouraging efficacy in patients with HR+/HER2- metastatic breast cancer who are resistant to CDK4/6 inhibitors, with manageable safety profiles observed. Ongoing studies include a combination trial of TYK-00540 with fulvestrant aimed at further addressing unmet clinical needs.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. TYK Medicines Inc. published the original cont","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251021:nNDL7sF17S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02410"],"gpt_icon":0},{"id":"1149235188","title":"TYK MEDICINES-B (02410): Positive Clinical Data on Multiple CDK Inhibitors Presented at ESMO 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=1149235188","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1149235188?lang=en_us&edition=fundamental","pubTime":"2025-10-21 20:14","pubTimestamp":1761048849,"startTime":"0","endTime":"0","summary":"TYK MEDICINES-B (02410) announced that its board is pleased to share early clinical research results for three cell cycle-dependent kinase inhibitors (CDK inhibitors), TYK-00540 (CDK2/4i), TY-2699a...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02410","159938","BK1574","09939","BK1161","BK1515"],"gpt_icon":0},{"id":"1102423374","title":"TYK MEDICINES-B (02410) Proposes Adoption of 2025 H-Share Incentive Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=1102423374","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1102423374?lang=en_us&edition=fundamental","pubTime":"2025-10-14 22:50","pubTimestamp":1760453414,"startTime":"0","endTime":"0","summary":"TYK MEDICINES-B (02410) announced that the board of directors proposes to adopt the 2025 H-share incentive plan.","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159938","02410","BK1161","09939","BK1574","BK1515"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":3,"totalSize":62,"code":"91000000","status":"200"}]}}